Barbara Karakyriakou

Also affiliated with Harvard University, Massachusetts General Hospital, Dartmouth Psychiatric Research Center, Center for Cancer Research

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “DrugMap: A quantitative pan-cancer analysis of cysteine ligandability”.

DrugMap: A quantitative pan-cancer analysis of cysteine ligandability

Cell(2024)10.1016/j.cell.2024.03.027

N/A

0.686DataRank · unranked

96 citations

Harrison B. Chong, Siwen Zhang, Tzu-Yi Yang, Matthew J. Lazarov, Stefan Harry +66 more

DrugMap: A quantitative pan-cancer analysis of cysteine ligandability

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.20.563287

N/A

0.330DataRank · unranked

8 citations

Harrison B. Chong, Siwen Zhang, Matthew J. Lazarov, Stefan Harry, Michelle Maynard +64 more

Quantitative proteomics analysis of triple-negative breast cancers

npj Precision Oncology(2025)10.1038/s41698-025-00907-8

N/A

0.305DataRank · unranked

5 citations

Jonathan D. Marotti, Youdinghuan Chen, Barbara Karakyriakou, Roberto Salgado, Brock C. Christensen +3 more

Collateral lethality between HDAC1 and HDAC2 exploits cancer-specific NuRD complex vulnerabilities

Nature Structural & Molecular Biology(2023)10.1038/s41594-023-01041-4

N/A

0DataRank · unranked

34 citations

David Remillard, Ugoma Onubogu, Barbara Karakyriakou, Joshua N. Asiaban, Anissa R. Ramos +10 more

Targeted degradation of the enhancer lysine acetyltransferases CBP and p300

Cell chemical biology(2021)10.1016/j.chembiol.2020.12.004

N/A

0DataRank · unranked

163 citations

Jan Fehmi Sayılgan, Samuel Ojeda, Barbara Karakyriakou, Eileen Hu, Johannes Kreuzer +7 more

Collateral lethality between HDAC1 and HDAC2 exploits cancer-specific NuRD complex vulnerabilities

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.05.30.493851

N/A

0DataRank · unranked

2 citations

David Remillard, Ugoma Onubogu, Barbara Karakyriakou, Joshua N. Asiaban, Anissa R. Ramos +7 more

TRIM33 Is a Co-Regulator of Estrogen Receptor Alpha

Cancers(2024)10.3390/cancers16050845

N/A

0DataRank · unranked

4 citations

Barbara Karakyriakou, Lauren Cressey, Brooke L. Brauer, Huijuan Yang, Alexa Warren +4 more